Related Experiment Video
Updated: Jun 3, 2026

10:50
Use of Pre-Assembled Plastic Microfluidic Chips for Compartmentalizing Primary Murine Neurons
Published on: November 2, 2018
Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies.
Anja Kunze1, Robert Meissner, Serena Brando
1Laboratoire de Microsystèmes LMIS4, Ecole Polytechnique Fédérale de Lausanne, Station 17, CH-1015 Lausanne, Switzerland. anja.kunze@epfl.ch
Biotechnology and Bioengineering
|March 11, 2011
Summary
This study introduces a new Alzheimer disease model using microfluidics to create connected healthy and diseased neurons. This model allows studying disease propagation and drug effects in real-time.
Area of Science:
- Neuroscience
- Cell Biology
- Biomedical Engineering
Background:
- Alzheimer disease is characterized by Tau protein hyperphosphorylation.
- Current in vitro models often lack the complexity to study disease propagation between connected neuronal populations.
- Investigating cellular mechanisms of neurodegeneration requires sophisticated experimental systems.
Discussion:
- A novel microfluidic device enables the culture of primary cortical neurons in separated compartments.
- A neurite network connects these compartments, allowing for intercellular communication.
- Okadaic acid (OA) perfusion creates a localized gradient, inducing Tau hyperphosphorylation in a subset of neurons.
Key Insights:
- This model successfully establishes co-pathological states within connected neuronal networks.
- Distinct phosphorylation states of Tau protein (p-Tau) were confirmed using anti-phosphorylated tau (Ser262) staining.
- Synaptophysin staining verified the functional connectivity between healthy and diseased neuronal populations.
Outlook:
- This model provides a platform for studying the propagation of Tau pathology in Alzheimer disease and other tauopathies.
- It facilitates the investigation of simultaneous drug effects on both healthy and diseased neuronal populations.
- Future research can explore intercellular signaling and therapeutic interventions in a more physiologically relevant in vitro setting.

